Cargando…

Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma

Monoclonal antibody G250 (mAbG250) recognizes a determinant on carbonic anhydrase IX (CAIX). CAIX is expressed by virtually all renal cell carcinomas of the clear cell type (ccRCC), but expression in normal tissues is restricted. The homogeneous CAIX expression in ccRCC and excellent targeting capab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oosterwijk-Wakka, Jeannette C., Boerman, Otto C., Mulders, Peter F. A., Oosterwijk, Egbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709739/ https://www.ncbi.nlm.nih.gov/pubmed/23759990 http://dx.doi.org/10.3390/ijms140611402

Ejemplares similares

Combination of sunitinib and (177)Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2022)

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2015)

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas
por: Uemura, H, et al.
Publicado: (1999)

Antibody therapy in renal cell carcinoma
por: Oosterwijk, Egbert, et al.
Publicado: (2008)

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
por: Bleumer, I, et al.
Publicado: (2004)

Radiolabeled antibodies in renal cell carcinoma
por: Stillebroer, Alexander B., et al.
Publicado: (2007)

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX
por: Lenferink, Anne E.G., et al.
Publicado: (2021)

Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model
por: Merkx, Robin I. J., et al.
Publicado: (2022)

Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.
por: Steffens, M. G., et al.
Publicado: (1998)

Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies
por: Kciuk, Mateusz, et al.
Publicado: (2022)

Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours
por: Ahlskog, J K J, et al.
Publicado: (2009)

Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models
por: Huizing, Fokko J., et al.
Publicado: (2021)

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors
por: Testa, Chiara, et al.
Publicado: (2022)

Carbonic anhydrase IX in oligodendroglial brain tumors
por: Järvelä, Sally, et al.
Publicado: (2008)

Targeting Carbonic Anhydrase IX Activity and Expression
por: Mahon, Brian P., et al.
Publicado: (2015)

Carbonic Anhydrase IX—Mouse versus Human
por: Takacova, Martina, et al.
Publicado: (2019)

Carbonic anhydrase IX and acid transport in cancer
por: Becker, Holger M.
Publicado: (2019)

Novel humanized monoclonal antibodies for targeting hypoxic human tumors via two distinct extracellular domains of carbonic anhydrase IX
por: Zatovicova, Miriam, et al.
Publicado: (2022)

Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients
por: Závada, J, et al.
Publicado: (2003)

Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification
por: Betof, A S, et al.
Publicado: (2012)

Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management
por: Courcier, Jean, et al.
Publicado: (2020)

Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
por: McDonald, Paul C., et al.
Publicado: (2012)

Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness
por: Ward, Carol, et al.
Publicado: (2018)

Biophysical Characterization of Cancer-Related Carbonic Anhydrase IX
por: Koruza, Katarina, et al.
Publicado: (2020)

Carbonic Anhydrases II, IX, and XII in Reflux Esophagitis
por: Nortunen, Minna, et al.
Publicado: (2021)

Primary Duodenal Adenocarcinoma Expressing Carbonic Anhydrase IX
por: Kubo, Kimitoshi, et al.
Publicado: (2022)

Expression and prognostic value of carbonic anhydrase IX (CA-IX) in bladder urothelial carcinoma
por: Xiang, An-Ping, et al.
Publicado: (2022)

Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with (111)In-girentuximab
por: van Oostenbrugge, Tim J., et al.
Publicado: (2019)

New Monoclonal Antibodies for a Selective Detection of Membrane-Associated and Soluble Forms of Carbonic Anhydrase IX in Human Cell Lines and Biological Samples
por: Stravinskiene, Dovile, et al.
Publicado: (2019)

Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX
por: McDonald, Paul C., et al.
Publicado: (2018)

Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study
por: Hekman, Marlène C., et al.
Publicado: (2018)

Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer
por: Brown-Glaberman, Ursa, et al.
Publicado: (2016)

The Expression of Carbonic Anhydrases II, IX and XII in Brain Tumors
por: Haapasalo, Joonas, et al.
Publicado: (2020)

Carbonic anhydrase IX as a novel candidate in liquid biopsy
por: Ozensoy Guler, Ozen, et al.
Publicado: (2019)

Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy
por: de Campos, Najla Santos Pacheco, et al.
Publicado: (2022)

Structure and Dynamics of the Isozymes II and IX of Human Carbonic Anhydrase
por: Rai, Divya, et al.
Publicado: (2022)

Imaging of carbonic anhydrase IX with an (111)In-labeled dual-motif inhibitor
por: Yang, Xing, et al.
Publicado: (2015)

Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer
por: Span, P N, et al.
Publicado: (2007)

Expression of carbonic anhydrases IX and XII during mouse embryonic development
por: Kallio, Heini, et al.
Publicado: (2006)

Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer
por: Korkeila, E, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2j5rbtfq2951406ia7sfn9oglt